Opportunities and challenges in targeting orphan nuclear receptors
Chemical Communications · 2023
DOI: 10.1039/d3cc00954h ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2023. Verfasst von Laura Isigkeit und 1 weiteren Autor:innen. Beteiligte Einrichtung: Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, 60438 Frankfurt, Germany. daniel.merk@cup.lmu.de. Hauptthemen laut MEDLINE: Orphan Nuclear Receptors, Drug Discovery. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 131 Literaturangaben.
Abstract (Originalsprache)
Nuclear receptor modulation enables pharmacological control of gene expression and holds great therapeutic potential. Chemical tools are lacking for many nuclear receptors but needed to reveal new therapeutic opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, 60438 Frankfurt, Germany. daniel.merk@cup.lmu.de.
- Ludwig-Maximilians-Universität München, Department of Pharmacy, 81377 Munich, Germany.
Zitieren
APA
Isigkeit, L., & Merk, D. (2023). Opportunities and challenges in targeting orphan nuclear receptors. Chemical Communications. https://doi.org/10.1039/d3cc00954h
Vancouver
Isigkeit L, Merk D. Opportunities and challenges in targeting orphan nuclear receptors. Chemical Communications. 2023. doi:10.1039/d3cc00954h
BibTeX
@article{Isigkeit2023,
author = {Isigkeit, Laura and Merk, Daniel},
title = {Opportunities and challenges in targeting orphan nuclear receptors},
journal = {Chemical Communications},
year = {2023},
doi = {10.1039/d3cc00954h}
}
EUVIMED